Ninety percent of the applications to our Maximizing Investigators’ Research Award for Early Stage Investigators (known as the ESI MIRA program) that were submitted in October are about to undergo peer review. The remaining 10% were administratively withdrawn, mostly because the research proposed fell outside the NIGMS mission. This is comparable to the proportion that …
Continue reading “How do I know if my work fits in the mission of NIGMS?”
Prospective applicants frequently ask us whether their application ideas fit within our mission. NIGMS supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. We also support research in some specific clinical areas that affect multiple organ systems, including anesthesia, sepsis, wound healing, …
Continue reading “Does your application fit the scientific mission of NIGMS?”
UPDATE: Figure 2 of this post was updated slightly in March 2021 to reflect NIGMS-supported Early Stage Investigator counts more accurately. On September 28, 2018, the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 was signed into law. The law includes an NIGMS budget …
Continue reading “Application and Funding Trends in Fiscal Year 2018”
NIGMS, along with other NIH Institutes and Centers, has partnered with the National Institute on Aging to grow the community of scientists actively engaged in research focused on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD). Details of this year’s AD/ADRD supplement program are provided in NIA’s Notice NOT-AG-18-008. If your research, research training, or research …
Continue reading “Administrative Supplements to Add Research on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias”
NIGMS is committed to ensuring that taxpayers get the best possible returns on their investments in fundamental biomedical research. As part of this commitment to stewardship [PDF 7.89MB], we regularly monitor trends in our funding portfolio. We recognize the value of a diversified investment portfolio and approach our research investments in a similar fashion. Sustaining …
Continue reading “Application and Funding Trends in Fiscal Year 2017”
Current Contributors Dr. Jon Lorsch As NIGMS director, Jon oversees the Institute’s research, training, and other programs. He’s committed to engaging the scientific community on a wide range of topics, including funding policies and trends, research evaluation, and workforce development and diversity. Dr. Alexandra Ainsztein A cell biologist, Alexandra manages grants in the areas of …
Continue reading “About the Authors”
Watch the MIDAS presentation at the September Advisory Council meeting. At its September 2017 meeting, our Advisory Council endorsed the concept of a MIDAS Coordination Center. MIDAS, or the Models of Infectious Disease Agent Study program, is a collaborative network of research groups that focus on developing bioinformatics tools and computational models to understand the …
Continue reading “Notice: Concept Clearance for MIDAS Coordination Center”
The 2017 Training, Workforce Development, and Diversity (TWD) Program Directors’ Meeting, organized through a grant to the Federation of Associations for Experimental Biology, took place June 18-21 in Baltimore. This biennial meeting brought together the community of faculty, staff and administrators who manage TWD undergraduate and predoctoral training programs across the nation to network, share best practices for …
Continue reading “Notes from the 2017 Training, Workforce Development, and Diversity Program Directors’ Meeting”
One question that has been asked about the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators is how awardees will be affected by the fact that they cannot have additional NIGMS research grants. In response to this question, we reviewed the research project grant (RPG) funding history of all 707 Principal Investigators (PIs) who …
Continue reading “A Historical Analysis of NIGMS Early Stage Investigators’ Awards and Funding”
NIGMS is committed to ensuring that taxpayers get the best possible returns on their investments in fundamental biomedical research. As part of an NIH-wide commitment to enhancing stewardship, we regularly monitor trends in the Institute’s funding portfolio. One of the most commonly cited metrics when discussing grants is success rate, calculated as the number of …
Continue reading “Stable Success Rates and Other Funding Trends in Fiscal Year 2016”
